Transitioning Between Viral & NonViral Platforms to Enhance CAR-T Safety & Durability
- Transitioning from a viral to non-viral platform for a cell therapy
- Overexpression of genes to enhance CAR-T function using a non-viral strategy for pediatric rare disease